Antibody responses induced by inactivated SARS-CoV-2 virus in healthcare workers at a rural hospital in Indonesia

Efrisca M. Br. Damanik; Herman P.L. Wungouw; Anita Lidesna Shinta Amat

doi:10.51248/.v43i5.2801

Authors

Efrisca M. Br. Damanik
Herman P.L. Wungouw
Anita Lidesna Shinta Amat

DOI:

https://doi.org/10.51248/.v43i5.2801

Keywords:

COVID-19, immunological, health workers, vaccination

Abstract

Introduction and Aim: Vaccines from various manufacturers have shown their efficacy against COVID-19 globally. In this study, the aim was to evaluate the immune response in subjects after the second vaccination with inactivated SARS-CoV-2 virus at Mamami Hospital located in a rural area in Indonesia.

Materials and Methods: The study employed a cross-sectional research design. The research took place at Mamami Hospital, Kupang City, East Nusa Tenggara, Indonesia, from April 5 to August 8, 2021. The research comprised a total of 30 health workers who served as the participants in this study.

Results: Immunoserology results show that 1 respondent was non-reactive and 2 had antibody results < 10. There were 7 respondents with antibody results > 10 - 40. Serological antibodies > 40 - 80 were found in 3 respondents. Serological antibodies > 80 - 120 were not found. Serological antibodies > 120 - 160 were found in 3 respondents. One respondent had serological antibodies ranging from 160 to 200, while 13 respondents had antibodies ranging from 200 to 400.

Conclusion: In the present study, inactivated SARS COV-2 virus vaccine significantly contributed to the acquisition of anti-SARS-CoV-2S antibodies of 30 health workers.

Author Biographies

Efrisca M. Br. Damanik

Department of Anatomical Pathology, Faculty of Medicine, and Veterinary Medicine, Universitas Nusa Cendana, Kupang, Indonesia

Herman P.L. Wungouw

Department of Radiology, Faculty of Medicine, and Veterinary Medicine, Universitas Nusa Cendana, Kupang, Indonesia

Anita Lidesna Shinta Amat

Department of Biochemistry, Faculty of Medicine, and Veterinary Medicine, Universitas Nusa Cendana, Kupang, Indonesia

References

Otsuka, S., Hiraoka, K., Suzuoki, M., Ujiie, H., Kato, T., Yokota, I., et al., Antibody responses induced by the BNT162b2 mRNA COVID 19 vaccine in healthcare workers in a single community hospital in Japan. Journal of Infection and Chemotherapy. 2022;28(4): 539-542.

Devendra, S., Vishnu, A. A review on the COVID 19, its history, diagnostic approaches, role of herbs and current world scenario. Biomedicine. 2021 Sep 7;41(2):328-332.

Heriyanto, R. S., Kurniawan, A., Wijovi, F., Halim, D. A., Jodhinata, C., Marcella, E., et al., The role of COVID 19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical ear medical students in Indonesia. International Journal of Infectious Diseases. 2022; 113: 336-338.

Dinc, H. O., Saltoglu, N., Can, G., Balkan, I. I., Budak, B., Ozbey, et al., Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection. Vaccine. 2022;40(1): 52-58.

Bencharattanaphakhi, R., Rerknimitr, P. Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis. JAAD case reports. 2021; 18: 1-3.

Cucunawangsih, C., Wijaya, R. S., Lugito, N. P. H., Suriapranata, I. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia. International Journal of Infectious Diseases. 2021; 113:15-17.

Souza, W. M., Amorim, M. R., Sesti-Costa, R., Coimbra, L. D., Brunetti, N. S., Toledo-Teixeira, D. A., et al., Neutralisation of SARS-CoV-2 lineage P. 1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study. The Lancet Microbe. 2021; 2(10): e527-e535.

Liu, J., Yan, W., Liu, Z., Han, Y., Xia, Y., Yu, J. A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination. Medicine in Novel Technology and Devices. 2021; 11: 100084.

Earle, K. A., Ambrosino, D. M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P. B., Siber, G. et al., Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021; 39(32): 4423-4428.

Emel, A. Z. A. K., Karadenizli, A., Uzuner, H., Karakaya, N., Canturk, N. Z., Hulagu, S. Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection. International Journal of Infectious Diseases. 2021; 113: 58-64.

Calil, V. M. L. T., Palmeira, P., Zheng, Y., Krebs, V. L. J., Carvalho, W. B. D., Carneiro-Sampaio, M. CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk. Clinics. 2021;76.

Yu, Y. P., Chen, J. T., Jiang, Z. W., Ling, W. A. N. G., Yu, C. K., Yan, X. Y., et al., Modeling the Long-term Antibody Response and Duration of Immune Protection Induced by an Inactivated, Preservative-free Hepatitis A Vaccine (Healive) in Children. Biomedical and Environmental Sciences. 2020; 33(7): 484-492.

Kim, J. H., Hotez, P., Batista, C., Ergonul, O., Figueroa, J. P., Gilbert, et al., Operation Warp Speed: implications for global vaccine security. The Lancet Global Health. 2020;9(7): e1017-e1021.

Su, Q. D., Zou, Y. N., Yi, Y., Shen, L. P., Ye, X. Z., Zhang, Y., et al., Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response. Vaccine. 2020; 39(8):1241-1247.